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Pathogenesis of hantavirus infections is poorly understood. Puumala virus (PUU) is the etiologic agent of nephropathia 
epidemica, a form of hemorrhagic fever with renal syndrome common in Europe. We have studied PUU infection in primary 
human monocyte/macrophagee and specifically the role of interferon ez (IFN-e) and cell differentiation i it. PUU infection 
proceeded at a low level in monocyte/macrophages, and nucleocapsid (N) protein accumulation started 2 days postinfection. 
IFN-induced antiviral MxA protein was detected 3 days postinfection, suggesting IFN-e production in culture. IFN-~ titers 
remained low, proposing that PUU is a poor IFN inducer. However, the PUU-induced IFN had an inhibitory effect on virus 
production as was shown by the effect of anti-IFN-e~. Pretreatment of cells with IFN-a caused a dose-dependent inhibition 
of PUU N accumulation and reduced the yield of infectious virus. Monocytic U-937 cells overexpressing MxA protein were 
susceptible to PUU, suggesting that, unlike in some other negative strand RNA virus infections, MxA does not mediate 
resistance to PUU infection. Differentiation f monocyte/macrophages in culture and treatment of THP-1 promonocytic cells 
with phorbol 12-myristate 13-acetate made the cells more susceptible to PUU. The increased susceptibility of mature 
macrophages to PUU suggests that after differentiation to tissue macrophages they might function in the spread of the 
virus during PUU infection. © 1995 Academic Press, lnc. 
INTRODUCTION 
Puumala virus (PUU) is a member of the Hantavirus 
genus in the Bunyaviridae family. Hantaviruses are enve- 
loped negative strand RNA viruses with three genome 
segments coding for the nucleocapsid (N), envelope gly- 
coproteins (G1 and G2), and RNA polymerase/tran- 
scriptase enzyme, respectively (Elliott et aL, 1991). They 
are a group of human pathogenic and apathogenic vi- 
ruses distributed widely and carried by rodent hosts (Lee 
eta/., 1990; Antic et a/., 1992). The genetic diversity of 
the viruses follows the family tree of the host animals 
(Vapalahti et aL, 1992; Plyusnin eta/., 1994). Pathogenic 
hantaviruses cause an acute febrile illness characterized 
by headache and myalgia as well as renal failure and 
hemorrhages with 2 to 10% mortality rates, as in the 
typical cases of the related Seoul and Hantaan virus 
infections. Puumala virus, carried by Clethrionomys 
glareolus (Brummer-Korvenkontio et aL, 1980), is closely 
related to the apathogenic Prospect Hill virus and is as- 
sociated with a mild form (mortality ~0.2%) of hemor- 
rhagic fever with renal syndrome (HFRS); it also occa- 
sionally causes pulmonary symptoms. Sin Nombre virus, 
a newly discovered member in the Hantavirus family, is 
most closely related to Puumala and Prospect Hill vi- 
ruses (Nichol etaL, 1993; Hjelle eta/., 1994). Rather than 
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HFRS, Sin Nombre virus infection is characterized by 
prominent pulmonary symptoms (hantaviral pulmonary 
syndrome, HPS), where rapidly progressing noncardio- 
genic edema leads to death in ~75% of the cases (Nichol 
et al., 1993; Duchin et aL, 1994). This confirms that the 
growing family of hantaviruses includes important patho- 
gens and attaches additional value to their research. 
Hantavirus pathogenesis is poorly understood, but an 
increase in endothelial celt permeability in the affected 
tissues, kidneys in HFRS and lungs in HPS, is considered 
to be essential. In autopsy specimens of lethal hantavirus 
cases viral antigen and genome have been detected in 
endothelial cells, e.g., in the lungs and the kidneys 
(Xhang eta/., 1987; Nichol eta/., 1993). Hantaviruses are 
noncytopathic, and therefore immunological responses 
and cytokines may be involved in the tissue damage 
(Cosgriff, 1991). We demonstrated earlier that PUU has 
a wide cell susceptibility in vitro: established human celt 
lines of lung, kidney, liver, pharynx, and submaxillary 
gland origin as well as primary kidney glomerular cells, 
endothelial cells, and monocyte/macrophages can sus- 
tain virus replication (Temonen eta/., 1993). 
It has been suggested that macrophages may contrib- 
ute to the spread of hantavirus infection (Nagai et aL, 
1985; Temonen et al., 1993). Hantaan virus propagates 
in monocyte/macrophages in vitro (Nagai eta/., 1985) 
and antibody-dependent enhancement of infection has 
been described in these cells (Yao et a/., 1992). Hantaan 
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virus has been isolated from peripheral blood mononu- 
clear cells during the febrile phase of the disease (Yao 
et al., 1989). 
Monocyte/macrophages are immunologically im- 
portant cells since they can produce, e.g., type I interfer- 
ons (IFN-G and -/3) and other inflammatory cytokines. The 
regulatory rote of IFN-/3 on Hantaan virus infection has 
been demonstrated in human endothelial cells (Pensiero 
et al., 1992) and murine macrophages, and IFN-G, -fl, 
and -T have been shown to restrict Hantaan virus growth 
in Vero E6 monkey kidney cells (Tamura et aL, 1987). 
The antiviral, antiproliferative, and immunomodulatory 
functions of interferons are mediated by IFN-induced in- 
tracellular proteins (Sen and Ransohoff, 1993). At least 
four different protein systems, 2-5A-activated RNase L, 
p68 protein kinase, HIV rev response element binding 
protein, and Mx protein, mediate cellular resistance to 
different viruses. Human MxA protein, a cytoplasmic 72- 
kDa GTPase, is known to be active on influenza, measles, 
and vesicular stomatitis (VSV) viruses, which all are enve- 
loped single-stranded negative-sense RNA viruses 
(Pavlovic et al., 1990; Staeheli et aL, 1991 ; Schnorr at aL, 
1993). 
We have now studied factors that influence PUU infec- 
tion in cultured peripheral blood monocyte/macrophages 
including the antiviral role of external and PUU-induced 
IFN-G and also the age-dependent differentiation of the 
cells. The ability of MxA protein to inhibit viruses with 
different replication strategies makes it a good candidate 
molecule also against hantaviruses; thus, the possible 
role of MxA as an antiviral protein in PUU infection was 
also examined. 
MATERIAL AND METHODS 
Viruses 
The prototype Sotkamo strain of Puumala virus 
adapted to Vero E6 cells (Karabatsos, 1985; Schmatjohn 
et al., 1985) was used at passages 9 to 24. The virus 
inoculurn was prepared by collecting the conditioned me- 
dium on Day 14 postinfection of Vero E6 cell cultures. In 
infection experiments the multiplicity of infection (m.o.i.) 
was 0.3. Virus was allowed to absorb for 1 hr at 37 °, the 
inoculum was removed, and cells were washed once 
and grown in RPMI 1640 medium supplemented with 
10% fetal calf serum (FCS), glutamine, penicillin, and 
streptomycin. Influenza virus A/Beijing/353/89 (H3N2) 
strain, kindly provided by Dr. Reijo Pyh~il~, National Pub- 
lic Health Institute, Helsinki, was grown in embryonated 
eggs. The titer of the stock virus was about 2 X 10 7 EIDso 
(egg infectious dose) and in the infection experiments 
the virus was used at a m.o.i, of 1-5. 
Cells 
Human peripheral blood buffy coat fractions of healthy 
blood donors were obtained from The Finnish Red Cross 
Blood Transfusion Service, Helsinki. To isolate mononu- 
clear cells, the buffy coat cells were suspended 1:1 in 
RPMI 1640 and centrifuged at 1500 rpm for 30 min 
through a FicolI-Paque cushion (Pharmacia, Uppsala, 
Sweden). The cells were washed twice with RPMI 1640 
medium and 10 7 cells were seeded per 10-cm 2 well to 
six-well Linbro dishes (Nunc, Roskilde, Denmark). After 
16 hr of adhesion nonadherent cells were removed by 
washing the cultures vigorously three times with RPMI 
1640. Adherent cells were regarded as monocyte/macro- 
phages but not formally identified. They reached macro- 
phage-like morphology as expected, after 3 to 10 days 
of culture (Johnston, 1993). 
Promonocytic THP-1 cells (American Type Culture Col- 
lection, Rockville, MD; ATCC TIB 202) were maintained 
at a density of 2-5 X 10 ~ cells/ml in RPMI 1640 supple- 
mented with 10% FCS, penicillin, and streptomycin. In 
order to differentiate THP-1 cells to macrophage-like 
cells, 107 cells were seeded per 53-cm 2 tissue culture 
plates and treated for 24 hr with 10 ng/ml of phorbol 12- 
myristate 13-acetate (PMA; Sigma, St Louis, MO). After 
24 hr of treatment about 80% of the cells adhered. The 
untreated cells did not adhere on culture plates, but they 
were infected at the same m.o.i, as PMA-treated adher- 
ent cells and grown similarly on culture plates. 
The promonocytic U-937 cell line stably transfected 
with the MxA gene (Schnorr eta/., 1993) and MxA-nega- 
tive control U-937 cells were kindly provided by Dr. Sib- 
ytle Schneider-Schaulies, Institute for Virology and Immu- 
nobiology, W0rzburg, Germany. More than 90% of the 
MxA+ cells expressed high levels of MxA. These cells 
were maintained and treated with PMA like THP-1 cells. 
Bovine kidney cell line MDBK (ATCC CCL 22, also 
known as NBL-1 cells) and Vero E6 cells (Schmaljohn 
et aL, 1985) were cultured in Eagle's Minimal Essential 
Medium (MEM) supplemented with 10% FCS, glutamine, 
penicillin, and streptomycin. 
Interferon and anti-interferon treatment 
The cells were pretreated for 24 hr with indicated con- 
centrations of IFN-e, after which the interferon-con- 
taining medium was removed prior to virus inoculation. 
Partially purified natural leukocyte interferon (Cantell et 
al., 1985) was used. Polyclonal sheep antiserum against 
IFN-~ was added to the medium after virus absorption 
in IFN-~-neutralizing concentrations of 4500 IU/ml (Mo- 
gensen et al., 1983). Both the IFN-tx and the antiserum 
were kindly provided by Dr. Karl Cantell, National Public 
Health Institute, Hetsinki. 
Gel electrophoresis (SDS-PAGE) and immunoblotting 
Cells in the culture dish were collected from culture 
plates with a rubber policeman, washed with phosphate- 
buffered saline (PBS), pH 7.4, and suspended in 200 #1 
of either Laemmli's sample buffer (Laemmli, 1970) or, 
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for protein determination by BCA protein assay reagents 
(Pierce, Rockford, IL), in PBS with 0.1% SDS. Equal vol- 
umes of dissolved cells in Laemmli's buffer (by estimation 
about 50,000 cells) or amounts of protein (8-30 #g) were 
analyzed in immunoblotting. The proteins were sepa- 
rated by SDS-PAGE. Polyclonal rabbit antibodies raised 
against PUU nucleocapsid fl-galactosidase fusion pro- 
tein (Vapalahti et aL, 1992), influenza A nucleocapsid 
protein, or MxA protein (Ronni etaL, 1993) were used as 
primary antibodies in 1=500 dilution in PBS containing 5% 
nonfat milk to block unspecific binding, and peroxidase- 
conjugated anti-rabbit-lgG (Dakopatts, Glostrup, Den- 
mark) in 1=1000 dilution as the secondary antibody. The 
bands were visualized with enhanced chemilumines- 
cence (ECL) immunoblotting reagents (Amersham, Ayles- 
bury, England) and exposed on Kodak films (Kodak, 
Rochester, NY). Optical density of the bands was quanti- 
tated with a Millipore Biolmage scanner (Millipore, Bed- 
ford, MA). 
Immunofluorescence 
Cells 5-10 x 104 were fixed with ice-cold acetone on 
glass slides and stained with PUU-N antibodies in 1:50 
dilution. FITO-conjugated secondary anti-rabbit IgG anti- 
bodies (Dakopatts) were used in 1:30 dilution. 
Virus titration 
Puumala virus titers from monocyte/macrophage cul- 
ture medium were determined using an immunofluores- 
cence plaque assay test in Vero E6 cells (Niklasson et 
aL, 1991 ) with minor modifications. Samples of monocyte/ 
macrophage culture media were collected on the indi- 
cated days postinfection before the cells were harvested 
for immunoblotting. Virus was absorbed onto Vero E6 
cells for 1 hr and then removed and 0.5% agarose con- 
taining 1000 IU/ml neutralizing units of IFN-c~ antiserum 
was layered over the cells. After 7 days the agarose 
was removed and the cells were fixed with methanol. 
Convalescent-phase patient antiserum to PUU in 1,50 
dilution was used as the primary antibody in the immuno- 
fluorescence staining of infected foci followed by fluores- 
cein-conjugated secondary antibodies to human IgG 
(Kallestad, Freiburg, Germany) in 1,30 dilution. The virus 
titers are given as plaque forming units (PFU)/ml medium 
or as multiplicities of infection (m.o.i.). 
Biological assay of interferon 
Interferon concentrations in monocyte/macrophage 
culture media were determined by a plaque reduction 
assay described previously (Linnavuori, 1988). Samples 
of culture medium from infected monocyte/macrophages 
were collected and seeded with MDBK cells to 96-well 
flat-bottomed microtiter plates. After 24 hr 300-400 PFU 
of VSV were added per well and the plaques were visual- 
ized with crystal violet staining after another 24-36 hr of 
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FIG. 1. Immunoblotting of viral nucleocapsid and IFN-induced MxA 
protein in PUU-infected primary monocyte/macrophages. (A) Adherent 
cells were infected with PUU and equal amounts of cells were analyzed 
at different ime points after infection. Immunoblots of SDS-PAGE- 
separated proteins were prepared simultaneously with specific anti- 
bodies to PUU-N (49 kDa) and MxA (72 kDa) proteins. (B) Quantitation 
of optical densities of the MxA and PUU-N protein specific bands on 
panel A performed by scanning the original ECL autoradiographs. 
incubation. The number of plaques was compared to 
those obtained in the presence of IFN-a (from 1 to 20 
lU/ml). VSV, Indiana strain, was provided by Dr. Kimmo 
Linnavuori, Department of Virology, University of Helsinki. 
RESULTS 
Kinetics of PUU infection in monocyte/macrophages 
and induction of IFN-a 
To follow the time course of PUU infection we infected 
16-hr-adhered peripheral blood monocytes. Accumula- 
tion of PUU N was visualized by immunoblotting and the 
bands were quantitated by Biolmage scanner (Fig. 1). A 
faint PUU N band, which apparently originated from the 
input virus, was observed at 4 to 24 hr postinfection. In 
these cells PUU replication was slow; a clear increase 
in the amount of PUU N was seen only at 2 days postin- 
fection. Immunofluorescence analysis of the infected 
iNTERFERON, PUUMALA VIRUS, AND MONOCYTE/MACROPHAGES 11 
FiG. 2. PUU-N specific immunofluorescence staining of monocyte/ 
macrophages detached from their culture plates to glass slides. Immu- 
nofluorescence staining pattern of uninfected monocytes 16 hr after 
adhesion (a), uninfected cells 6 days postadhesion (b), PUU-infected 
16-hr-adhered cells 6 days postinfection when 7% were positive for 
PUU-N (c), and infected 6-day-adhered cells 6 days postinfection when 
10% were positive for PUU-N (d). Arrows show PUU-positive cells (c 
and d). 
cells (Figs. 2c and 2d) also demonstrated that the infec- 
tion proceeded at a low level; 5-10% of monocyte/macro- 
phages were infected by Day 7, whereas by the same 
time 100% of Vero cells are infected (Temonen et al., 
1993). PUU infection did not cause any cytopathic effects 
on monocyte/macrophages but prolonged culturing re- 
sulted in morphological changes toward a macrophage- 
like phenotype as observed in light microscopy. 
The yields of infectious virus secreted to the medium 
were also measured (Fig. 5). Adherent monocyte/macro- 
phages produced low levels of infectious virus (5-30 
PFLI/ml medium) in 10 days (Figs. 5A and 5B). 
We tested both IFN release into cell culture superna- 
tant (data not shown) and expression of MxA by immu- 
noblotting (Fig. 1). Very low levels of type I IFN, 5-10 IU/ 
ml, were found in cell culture supernatants at late times, 
5 to 7 days postinfection. MxA protein expression, which 
can be induced also by low (<1 IU/ml) IFN-G concentra- 
tions (Ronni et aL, 1993), was clearly observed at 3 days 
postinfection (Fig. 1). The levels of MxA protein increased 
with time, suggesting that IFN-G was continuously pro- 
duced during the infection. 
Inhibition of PUU infection by IFN-a 
The effect of PUU-induced interferon on the course of 
infection was studied by adding IFN-a antibodies into 
the medium at concentrations of 4500 IFN-~ neutralizing 
units/ml. As shown in Fig. 3, anti-IFN-G suppressed the 
interferon action since MxA protein accumulation was 
inhibited as seen on Day 3 postinfection and onward. At 
the same time there was an enhancement in PUU N 
protein accumulation (Fig. 3), and also an increase in 
virus yield (Fig. 5B). This suggests that the interferon 
produced in response to virus infection had an inhibitory 
effect on PUU growth in monocyte/macrophages. 
External IFN-~ had a dose-dependent inhibitory effect 
on PUU infection. When 1-day-old cultures were pre- 
treated with 1000 IU/ml IFN-~ for 24 hr prior to infection 
a clear reduction could be seen in the accumulation of 
PUU N protein (Fig. 4) whereas 10 IU/ml gave only a 
partial suppression. The inhibitory effect of IFN-G was 
long lasting and was more clearly seen with 1000 IU/ml 
of IFN-G at later time points (on Day 5). Pretreatment of 
monocyte/macrophages with 1000 lU/ml of IFN-~ re- 
duced the amount of secreted virus to undetectable lev- 
els (Fig. 5A). A dose-dependent increase in MxA protein 
expression by IFN-G pretreatment was observed only on 
Day 1 postinfection (Fig. 4). Thereafter the levels of MxA 
were equally high and indicated virus-induced IFN-a pro- 
duction (not shown). 
As expected, the external IFN-ez treatment had an in- 
hibitory effect on the morphological differentiation of 16- 
hr-adhered monocyte/macrophages; the cells remained 
microscopically small in size. To test whether the inhibi- 
tory effect of IFN-a on PUU infection was dependent on 
cell differentiation, we also infected 5-day-old differenti- 
ated macrophage cultures (data not shown). Pretreat- 
ment of these cells with IFN-a (1000 IU/ml) for 24 hr 
inhibited accumulation of PUU N as compared to the 
untreated control cells. This result was similar as in cells 
infected 16 hr after adhesion (Fig. 4). AIsoanti-IFN-G 
increased PUU-N accumulation in cells infected after 5 
days (data not shown) or 16 hr post adhesion (Fig. 3). 
The result suggests that the inhibitory IFN-e effect on N 
protein accumulation was not mediated by the inhibition 
of cell differentiation. 
Role of MxA protein 
The role of MxA as an antiviral IFN-~-induced protein 
in PUU infection was studied by using MxA-expressing 
and nonexpressing monocytic U-937 cell lines (Schnorr 
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FIG. 3. Effect of anti-IFN-G on PUU infection. Adherent monocyte/ 
macrophages were infected with PUU and after the virus absorption 
sheep antiserum to IFN-oz was added (lanes 1, 3, 5, 7, and 9). The 
samples in lanes 2, 4, 6, 8, and 10 had no antiserum. Samples with 
equal amounts of cells were collected at the indicated time points for 
immunoblotting of PUU-N and MxA proteins. 
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FIG. 4. Dose-dependent inhibition of PUU N in IFN-a-pretreated monocyte/macrophages. Adherent cells were pretreated with 10, 100, or 1000 
IU/ml of tFN-o~ or left untreated (none), and then infected with PUU. C is an uninfected control. Samples with equal amounts of cells were collected 
at different ime points after infection. The histograms represent th  quantitation (optical densities) of the protein bands on ECL autoradiographs 
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FIG. 5. Production of progeny PUU by monocyte/macrophages. Virus 
secreted into medium at the time points indicated was titrated by 
plaque assay. Monocyte/macrophages (A and B) were adhered for 16 
hr and macrophages (C) for 4 days and then left untreated (O) or were 
treated with IFN-a (O) for 1 day before infection. Anti-IFN-a w s added 
after virus absorption (I). Each point of the curve corresponds to the 
mean of two samples. Absolute numbers of plaques varied to some 
degree between each titration but the relation of the resulted curves 
which are sh0wn in the figure remained the same. The titer of the input 
virus was 6 x 10 ~ PFU/ml. 
et aL, 1993). The cells overexpressing MxA protein (Fig. 
6, lanes 2 and 6) as wel l  as MxA-negative control cells 
(lanes 4 and 8) were  suscept ib le to PUU infection, as 
judged by the level of N protein accumulat ion,  suggest ing 
that MxA protein did not mediate resistance to the virus 
in these cells. The result was  s imi lar  in suspension cul- 
tures of U-937 cells (data not shown) and when the cells 
were induced by PMA to adhere to culture plates (Fig. 
6). No MxA protein-mediated inhibit ion was seen when 
10-fold lower  amounts of virus inoculum were Used (Fig. 
6, lanes 3 and 7 versus 5 and 9). 
The fact that even more PUU N accumulated in MxA+ 
cells than MxA-  cells (compare, e.g., lanes 2 and 4 in 
Fig. 6) may partly be due to the restricted cell division of 
the MxA+ transformed U-937 cell line compared to the 
MxA-  cells which mult ipl ied at a somewhat  faster rate. 
As a control for the antiviral function we infected U-937 
cells with influenza A virus. The accumulat ion of influenza 
A virus nucleocapsid protein was  inhibited in MxA+ 
transfected cells as compared to MxA-  cells (data not 
shown), conf irming that MxA protein had an antiviral ac- 
tion on this virus in U-937 ceils (Pavlovic et aL, 1990). 
Effect of cell d i f ferent iat ion on PUU infect ion 
Freshly seeded monocyte/macrophages,  when grown 
3 -5  days in culture, matured to the size of macrophages.  
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FtG. 6. The role of MxA protein i  PUU infection in U-937 cells. U- 
937 not expressing MxA (-) and u-g37 cell clone expressing stably 
transfected MxA gene (+) were treated with PMA then infected with 
PUU at a m.o.i, of 3 x 10 -~ (lanes 2, 4, 6, 8) or 3 x 10 -2 (lanes 3, 5, 
7, 9). Lane 1 represents uninfected U-937 MxA+ control. MxA expres- 
sion and the level of PUU-N accumulation were studied in these cells 
on days between 1 and 7 days postinfection and the 3rd- and the 7th- 
day samples are shown. For the PUU-N immunoblot 12 #g protein was 
used per lane and for the MxA immunoblot 6 #g was used. 
If the cells were infected 6 days after adherence, and 
were thus considered mature macrophages, the infection 
(accumulation of PUU N) proceeded more rapidly (Fig. 
7B) than when the cells were infected after a 16-hr cell 
adhesion (Fig. 7A), A higher final level of PUU N was 
also seen in macrophages (Fig. 7B and Fig. 2d). PUU 
induced slightly more interferon in cells that had been 
infected after differentiation (15 IU/ml) than in cells in- 
fected atthe monocytic stage (10 IU/ml) (data not shown), 
which also resulted in higher MxA protein expression 
levels (Fig. 7B). Differentiated monocyte/macrophages 
produced more virus (Fig. 50) than freshly seeded (16- 
hr-old) cells (Figs. 5A and 5B), but the infection was still 
FiG. 8. Effect of PMA treatment of THP-1 cells to PUU susceptibility. 
Promonocytic THP-1 cells were treated with PMA for 24 hr (A) or left 
untreated (B). Then the cells were infected with PUU and collected on 
the days indicated. Equal amounts of total cellular protein (30/~g) were 
analyzed by immunoblotting for PUU-N. The 0-day samples represent 
uninfected control cells. 
suppressed by interferon= anti-IFN-~ gave a remarkable 
increase in virus production in macrophages (Fig. 50). 
PMA treatmen't of the promonocytic THP-1 cells in- 
duced their differentiation, i.e., adhesion and morphologi- 
cal changes, and greatly enhanced accumulation of PUU 
N (Fig. 8A). On Day 1 postinfection the level of N protein 
was almost the same in PMA-treated (adherent, Fig. 8A) 
and untreated (suspension, Fig. 8B) THP-1 cell cultures. 
A clear-cut difference in N protein accumulation was 
observed 3 days postinfection. Virus titers in the condi- 
t ioned media of both PMA-treated and suspension cells 
were under detectable level or very low; thus the effect 
of PMA on the virus yield in THP-1 cells could not be 
determined. According to immunofluorescence the num- 
ber of infected THP-1 cells remained low (<1%). 
DISCUSSION 
We have earl ier shown that PUU has a wide host cell 
range and that the infection of human cells in vitro is s low 
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FiG. 7. Effect of cell differentiation on cell susceptibility. Monocytes were allowed to adhere onto tissue culture plates and were infected either 
after 16 hr (A) or 6 days (B) of adherence. Cell samples were collected and equal amounts of protein (17 #g) were analyzed by immunoblotting for 
accumulation of PUU-N and MxA protein at the indicated days postinfection. The quantitative histograms (optical densities) of PUU-N and MxA 
protein bands are shown below the original autoradiograms. 
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(Temonen et aL, 1993). We have now studied infection 
of monocytes/macrophages which, although susceptible, 
propagated the virus at a relatively low level. PUU replica- 
tion in monocyte/macrophages i restricted to some de- 
gree by the interferon which is induced in these cells as 
a response to the virus infection. This observation is 
consistent with the effects of interferons on other hantavi- 
rus infections, IFN-fl inhibits Hantaan virus infection in 
endothelial cells (Pensiero et al., 1992). However, the 
levels of interferon induced by PUU in monocyte/macro- 
phages were low and did not differ significantly during 
the infection of monocytes (up to 10 IU/ml) and more 
mature macrophages (15 IU/ml) as compared to the thou- 
sands of units per milliliter induced by, e.g., high-titer 
herpes simplex virus (HSV) (Linnavuori and Hovi, 1983). 
Also, external interferon pretreatment of monocyte/ 
macrophage cultures restricted accumulation of PUU nu- 
cleocapsid protein and the yield of infectious virus in a 
dose-dependent manner. During the first days of infec- 
tion, restriction of PUU N accumulation was not seen 
clearly in IFN-~-pretreated cells, even when a high IFN- 
(1000 IU/ml) concentration was used. Thereafter, a 
slow decline in N protein level was apparent. The kinet- 
ics of N reduction may be affected by the half life of N 
protein, which is presently unknown. It is possible that 
the main primary target of IFN-G is not suppression of 
PUU N. The release of infectious Puumala virus was also 
affected by IFN-G and thus the spread of the infection to 
neighboring cells may be restricted. 
A clear in vitro inhibitory effect of Puumala virus repli- 
cation by INF-a raises the possibility of its therapeutic 
use in clinical infections. Tamura et aL (1987) showed 
that INF-/9 treatment of Hantaan virus-challenged suck- 
ling mice increased their survival from lethal infection. 
However, in human studies INF-G has not been a very 
promising form of therapy in Hantaan virus infection (Gui 
et aL, 1987). This may be because in the symptomatic 
phase of the disease viremia is complete and thus IFN 
cannot prevent symptoms caused by immunological re- 
sponses or metabolic disturbances of infected tissues. 
If we had better diagnostic tools to detect an early han- 
tavirus infection there could be an opportunity for a trial 
with IFN-G treatment. 
MxA protein was induced in monocyte/macrophages 
during PUU infection, and apparently this is an indicator 
of virus-induced IFN-G production. IFN-G titers in the cell 
culture supernatants were low and became detectable 
only at late times (5-7 days) postinfection. Such small 
amounts of IFN-G were most likely used up by the cells 
thus turning on MxA protein expression, which was seen 
at earlier time points (starting from 3 days postinfection). 
Successful infection of both the stably MxA-expressing 
and the nonexpressing U-937 cell line with PUU gives 
no evidence that MxA protein, though induced during 
PUU infection in monocyte/macrophages, would mediate 
resistance to this virus. Other known or presently un- 
known IFN-induced proteins or combinations of their 
functions may be responsible for the inhibition of PUU 
replication in IFN-G-treated monocyte/macrophages. 
The maturation of monocytes to macrophages is 
known to enhance the replication of many viruses, e.g., 
herpes simplex (Daniels et al., 1978), polio (Soonti~ns 
and van der Veen, 1973), and rubella (van der Logt et 
aL, 1980). Promonocytic U-937 and THP-1 cells can be 
induced to differentiate into macrophage-like cells by 
PMA. These cells have been used as models of the 
monocyte/macrophage lineage, PMA induction in- 
creases the ability of U-937 cells to support, e.g., Pich- 
inde (Polyak et aL, 1991) and Rift Valley fever virus infec- 
tions (Lewis et aL, 1987). The longer the monocyte/mac- 
rophages stayed in culture before infection the better 
they were in producing PUU N protein and infectious 
virus. They also produced slightly more IFN than mono- 
cytes infected. 16 hr after adhesion, so that the amount 
of IFN produced cannot explain the differences in sus- 
ceptibility of monocyte/macrophages of different age to 
PUU. Thus we suggest that cellular differentiation in- 
creases PUU infection in primary monocyte/macro- 
phages. Also the effect of PMA treatment on cell suscep- 
tibility to PUU was clear and was possibly caused by 
differentiation of promonocytic cells into macrophage- 
like cells. However, a direct effect of PMA as a stimulator 
of virus infection has been described in HIV, PMA can 
activate HIV transcription through induction of transcrip- 
tion factor NF-KB (Nabel and Baltimore, 1987). PMA can 
also modulate TNF-G and IL-1 expression (Leopardi et 
aL, 1992) but the effect of these cytokines on PUU infec- 
tion is not presently known. 
Both monocytes and macrophages were susceptible 
to PUU. In peripheral blood there are no circulating mac- 
rophages, only monocytes, the half life of which in circu- 
lation is approximately 3 days. Blood monocytes migrate 
into tissues, e.g., lungs, liver, bone, and brain, where they 
differentiate into tissue macrophages (Johnston, 1993). 
Due to the fact that macrophages were able to yield 
infectious virus, these cells could serve as a source of 
virus to different organs during the generalized infection. 
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